Primavera and FountainVest Acquire Remaining EQT Stake in LBX Pharmacy
November 27, 2019
Primavera Capital Group and FountainVest Partners bought EQT Greater China’s remaining 24.78% stake in LBX Pharmacy Chain Joint Stock Company (LBX) at RMB 55.0 per share, in a transaction signed and closed on 27 November 2019. LBX is a leading discount pharmacy superstore chain founded in Hunan province that operates thousands of self-owned and sub-franchised drugstores across China; the sale represents a divestiture by EQT and a strategic ownership transition to the consortium.
- Buyers
- Primavera Capital Group, FountainVest Partners
- Targets
- LBX Pharmacy Chain Joint Stock Company (LBX)
- Sellers
- EQT Greater China (EQT Greater China II fund)
- Industry
- Healthcare Services
- Location
- Hunan, China
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
FountainVest Partners Acquires CFB Group from EQT Private Equity
December 30, 2021
Food & Beverage
FountainVest Partners has acquired CFB Group, a Shanghai-headquartered multi-brand food & beverage platform operator, from EQT Private Equity (EQT Mid Market fund). The transaction closed on 30 December 2021; under EQT's ownership CFB Group expanded to more than 1,100 stores and became the world's largest franchisee of Dairy Queen and a major Papa John's franchisee in China. FountainVest will assume ownership to support the company's next phase of growth.
-
EQT Private Equity and Goldman Sachs Asset Management Acquire Parexel from Pamplona Capital Management
July 2, 2021
Healthcare Services
EQT Private Equity (EQT IX) and Goldman Sachs Asset Management's Private Equity business have agreed to acquire Parexel from Pamplona Capital Management for an enterprise value of USD 8.5 billion. Parexel, a global clinical research organization co-headquartered in Durham, North Carolina and Newton, Massachusetts, employs more than 17,000 people and provides outsourced clinical development, regulatory, market access and consulting services to the pharma and biotech industry.
-
Fengate Private Equity Partners with eMAX Health (Platform Investment)
January 28, 2025
Healthcare Services
Fengate Private Equity has made a platform investment in eMAX Health, partnering with founder Julian Casciano who will remain a significant investor and continue to lead the company. The investment (managed on behalf of the LiUNA Pension Fund of Central and Eastern Canada) will support accelerated product development, capability expansion and growth of eMAX’s tech-enabled real-world evidence, market access and patient services offerings.
-
Primus Capital Makes Minority Investment in LiquidityBook
April 13, 2021
Cloud & SaaS
Primus Capital, a growth-oriented private equity firm, has made a minority growth investment in LiquidityBook to help the SaaS trading-platform provider scale its POEMS product, accelerate product development (including its proprietary FIX network LBX Connect), and support global expansion. The capital will fund enhancements to LiquidityBook’s LBX suite, new hires, and go-to-market expansion to serve a broader array of buy- and sell-side fund managers and financial institutions.
-
Aquiline Makes Majority Investment in Pharma Force Group LLC
December 31, 2023
Healthcare Services
Aquiline Capital Partners has made a majority investment in Pharma Force Group LLC, a U.S.-based provider of 340B administration software and pharmacy benefits management solutions. The partnership will support PharmaForce’s product expansion and strategic M&A plans to accelerate growth across hospitals and health clinics. Piper Sandler advised PharmaForce; transaction closed in Q4 2023 with financial terms undisclosed.
-
Equistone Partners Europe Acquires Majority Stake in Omnicare
August 14, 2019
Pharmaceuticals
Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.